News
A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...
Goats, horses and cows carry a bacterium that could become an effective weapon against increased antibiotic resistance in society. New research from the University of Copenhagen shows that signaling ...
6d
News-Medical.Net on MSNNew study maps bacterial communication to fight MRSA infectionsImagine two people talking over a walkie-talkie set. Successful communication depends on them being tuned to the same frequency.
The MC4R agonist targets rare genetic and hypothalamic obesity, with potential as a combination or maintenance therapy for general obesity alongside GLP-1 agents.
Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...
A 3D paper-based analytical device (3D-osPAD) with in situ gold signal amplification enables one-step, highly sensitive ...
6hon MSN
A research team led by the Leibniz-HKI in Jena has uncovered a new way in which the yeast Candida albicans can damage human ...
The sculpture represents a collagen molecule, the most abundant protein in the human body, and serves as “an allusion to the ...
Learn how striking the right balance with plant growth regulators can reduce fruit drop in 'Honeycrisp' without sacrificing ...
When graduate student Varun Raviprolu turned off the NMR magnet and checked the read‑out, he saw something no chemist ...
In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results